Literature DB >> 26226099

Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease.

Donghee Kim1, Goh Eun Chung2, Min-Sun Kwak2, Hyo Bin Seo3, Jin Hwa Kang3, Won Kim4, Yoon Jun Kim5, Jung-Hwan Yoon5, Hyo-Suk Lee5, Chung Yong Kim5.   

Abstract

BACKGROUND & AIMS: Some studies have examined correlations between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) with nonalcoholic fatty liver disease (NAFLD) or between VAT and NAFLD. We investigated the longitudinal association between body fat distribution (VAT vs SAT) and incidence and regression of NAFLD, adjusting for risk factors, in a large population-based cohort.
METHODS: We collected data from adults who underwent abdominal ultrasonography (to identify liver fat), abdominal fat computed tomography scan, and blood tests from March 2007 through December 2008. Each patient underwent an anthropometric assessment and completed a questionnaire about their medical history, physical activity, and diet. Our final analysis involved 2017 subjects from the initial cohort who participated in a voluntary follow-up health screen performed in 2011 and 2013. The median follow-up time was 4.43 years.
RESULTS: We found 288 incident cases of NAFLD; 159 patients had NAFLD regression during the follow-up period. An increasing area of VAT was associated with higher incidence of NAFLD in the multivariable analysis (highest quintile vs lowest quintile of VAT hazard ratio [HR], 2.23; 95% confidence interval [CI], 1.28-3.89; P for trend = .002; HR, 1.36 [per 1 standard deviation]; 95% CI, 1.16-1.59). An increased area of SAT was significantly associated with regression of NAFLD (highest quintile vs lowest quintile of SAT HR, 2.30; 95% CI, 1.28-4.12; P for trend = .002; HR, 1.36 [per 1 standard deviation]; 95% CI, 1.08-1.72).
CONCLUSIONS: In a large cohort study, larger areas of VAT were longitudinally associated with higher risk of incident NAFLD (during a period of approximately 4 years). In contrast, larger areas of SAT were longitudinally associated with regression of NAFLD. These data indicate that certain types of body fat are risk factors for NAFLD, whereas other types could reduce risk for NAFLD.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMI; Marker; NASH; Prognosis; Steatosis

Mesh:

Year:  2015        PMID: 26226099     DOI: 10.1016/j.cgh.2015.07.024

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  35 in total

1.  Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally-Derived Anthropometric Measures.

Authors:  Maya Balakrishnan; Hashem B El-Serag; Theresa Nguyen; Jonathan Hilal; Fasiha Kanwal; Aaron P Thrift
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-20       Impact factor: 11.382

2.  Atherogenic index of plasma combined with waist circumference and body mass index to predict metabolic-associated fatty liver disease.

Authors:  Shao-Jie Duan; Zhi-Ying Ren; Tao Zheng; Hong-Ye Peng; Zuo-Hu Niu; Hui Xia; Jia-Liang Chen; Yuan-Chen Zhou; Rong-Rui Wang; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2022-09-28       Impact factor: 5.374

Review 3.  Hydrogen sulphide in liver glucose/lipid metabolism and non-alcoholic fatty liver disease.

Authors:  Inês Mateus; Carina Prip-Buus
Journal:  Eur J Clin Invest       Date:  2021-10-25       Impact factor: 5.722

4.  Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis.

Authors:  Karn Wijarnpreecha; Aijaz Ahmed; Donghee Kim
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

5.  A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.

Authors:  Michelle T Long; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Jiantao Ma; Rohit Loomba; Raymond T Chung; Emelia J Benjamin
Journal:  Liver Int       Date:  2018-03-12       Impact factor: 5.828

Review 6.  Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals.

Authors:  Meaghan Phipps; Julia Wattacheril
Journal:  Frontline Gastroenterol       Date:  2019-12-13

7.  Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis.

Authors:  Qianyi Wang; Hong You; Xiaojuan Ou; Xinyan Zhao; Yameng Sun; Min Wang; Ping Wang; Yu Wang; Weijia Duan; Xiaoming Wang; Shanshan Wu; Yuanyuan Kong; Romil Saxena; Annette S H Gouw; Jidong Jia
Journal:  Hepatol Int       Date:  2019-09-26       Impact factor: 6.047

8.  Does NAFLD mediate the relationship between obesity and type 2 diabetes risk? evidence from the multi-ethnic study of atherosclerosis (MESA).

Authors:  Luis A Rodriguez; Alka M Kanaya; Stephen C Shiboski; Alicia Fernandez; David Herrington; Jingzhong Ding; Patrick T Bradshaw
Journal:  Ann Epidemiol       Date:  2021-07-19       Impact factor: 3.797

9.  Hepatic Steatosis and Ectopic Fat Are Associated With Differences in Subcutaneous Adipose Tissue Gene Expression in People With HIV.

Authors:  Curtis L Gabriel; Fei Ye; Run Fan; Sangeeta Nair; James G Terry; John Jeffrey Carr; Heidi Silver; Paxton Baker; LaToya Hannah; Celestine Wanjalla; Mona Mashayekhi; Sam Bailin; Morgan Lima; Beverly Woodward; Manhal Izzy; Jane F Ferguson; John R Koethe
Journal:  Hepatol Commun       Date:  2021-02-27

10.  Comparison of Visceral Fat Measures with Cardiometabolic Risk Factors in Healthy Adults.

Authors:  Kyoungjune Pak; Seung Hun Lee; Jeong Gyu Lee; Ju Won Seok; In Joo Kim
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.